Health Catalyst gains access to $100M in new financing

Health Catalyst, a data, analytics and decision support company, closed a series F equity and debt funding round with access to up to $100 million in capital. This brings up the company's value to more than $1 billion.

The company will use the new funds to expand Health Catalyst's technology and services offerings, including the Health Catalyst Data Operating System, a data warehouse and application development platform. It will also support the company's "expansion, already underway, into the life sciences and international markets," said Health Catalyst CEO Dan Burton.

OrbiMed, a healthcare public and private market investment firm, led the equity and debt funding round. Other investors were Sequoia Capital, UPMC Enterprises and Kaiser Permanente Ventures.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like